An Open-Label Randomized Active-Controlled Phase II Clinical Study to Assess the Efficacy and Safety of Afuresertib Plus Paclitaxel Versus Paclitaxel in Patients with Platinum-Resistant Ovarian Cancer (PROFECTA-II/GOG-3044).

Thomas J Herzog,John B Liao, Karen Finkelstein,Lyndsay Willmott,Wei Duan,John W Moroney, Joseph Buscema, Katie Campbell-Simms, Yong Yue,Susan Zweizig, Juan Liu, Xiaoyu Wang,Rong-Yu Zang,Rutie Yin,David M O'Malley,Lingying Wu

Gynecologic oncology（2025）

Cited 0|Views1

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined